Steineger Hilde H 4
4 · Strongbridge Biopharma plc · Filed May 18, 2021
Insider Transaction Report
Form 4
Steineger Hilde H
Director
Transactions
- Award
Ordinary Shares
2021-05-18+40,000→ 82,021 total
Footnotes (1)
- [F1]Represents a grant of restricted stock units, which vest in full on May 18, 2022, provided that the Reporting Person continues to serve as a member of the board of directors of the Issuer through that date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.